HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome

PHASE3RecruitingINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Postresuscitation Syndrome
Interventions
DRUG

Administration of AVP

Administration of AVP

DRUG

Administration of placebo AVP

Administration of placebo AVP

DRUG

Administration of placebo hydrocortisone

Administration of placebo hydrocortisone

DRUG

Administration of hydrocortisone

Administration of hydrocortisone

Trial Locations (14)

75014

RECRUITING

Intensive care unit, Cochin hospital, APHP, Paris

92100

WITHDRAWN

Medical Intensive Care Unit, Ambroise Paré hospital, APHP, Boulogne-Billancourt

92200

RECRUITING

Intensive care unit, Clinique Ambroise Paré, Neuilly-sur-Seine

Unknown

RECRUITING

Intensive care unit, CHU Amiens- Picardie, Amiens

RECRUITING

Intensive care unit, CHU Angers, Angers

RECRUITING

Intensive care unit, CHI Robert Ballanger, Aulnay-sous-Bois

RECRUITING

Intensive care unit, CH public du Cotentin, Cherbourg

RECRUITING

Intensive care unit, CHU Dijon, Dijon

RECRUITING

Intensive care unit, Hospices civils de Lyon, Lyon

RECRUITING

Intensive care unit, Hôpital Jacques Cartier, Massy

RECRUITING

Intensive care unit, CHU Montpellier, Montpellier

RECRUITING

Intensive care unit, Brabois hospital, Nancy

RECRUITING

Intensive care unit, Hotel Dieu hospital, Nantes

RECRUITING

Intensive care unit, André Mignot hospital, Versailles

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04591990 - HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome | Biotech Hunter | Biotech Hunter